AdvertisementAvandia Survives, As Experts Support Continued Sales, With CaveatsJuly 14, 2010Scott HensleyfacebookEmailAn expert panel voted to keep Avandia on the drug with beefed-up warnings and restrictions. But the FDA has the final say. (Getty Images)
